200 related articles for article (PubMed ID: 35389777)
21. Cancer regulatory variation.
Hennessey RC; Brown KM
Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
[TBL] [Abstract][Full Text] [Related]
22. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
[TBL] [Abstract][Full Text] [Related]
23. Recurrent somatic mutations in regulatory regions of human cancer genomes.
Melton C; Reuter JA; Spacek DV; Snyder M
Nat Genet; 2015 Jul; 47(7):710-6. PubMed ID: 26053494
[TBL] [Abstract][Full Text] [Related]
24. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
Lee CA; Abd-Rabbo D; Reimand J
Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
[TBL] [Abstract][Full Text] [Related]
25. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
Rheinbay E; Nielsen MM; Abascal F; Wala JA; Shapira O; Tiao G; Hornshøj H; Hess JM; Juul RI; Lin Z; Feuerbach L; Sabarinathan R; Madsen T; Kim J; Mularoni L; Shuai S; Lanzós A; Herrmann C; Maruvka YE; Shen C; Amin SB; Bandopadhayay P; Bertl J; Boroevich KA; Busanovich J; Carlevaro-Fita J; Chakravarty D; Chan CWY; Craft D; Dhingra P; Diamanti K; Fonseca NA; Gonzalez-Perez A; Guo Q; Hamilton MP; Haradhvala NJ; Hong C; Isaev K; Johnson TA; Juul M; Kahles A; Kahraman A; Kim Y; Komorowski J; Kumar K; Kumar S; Lee D; Lehmann KV; Li Y; Liu EM; Lochovsky L; Park K; Pich O; Roberts ND; Saksena G; Schumacher SE; Sidiropoulos N; Sieverling L; Sinnott-Armstrong N; Stewart C; Tamborero D; Tubio JMC; Umer HM; Uusküla-Reimand L; Wadelius C; Wadi L; Yao X; Zhang CZ; Zhang J; Haber JE; Hobolth A; Imielinski M; Kellis M; Lawrence MS; von Mering C; Nakagawa H; Raphael BJ; Rubin MA; Sander C; Stein LD; Stuart JM; Tsunoda T; Wheeler DA; Johnson R; Reimand J; Gerstein M; Khurana E; Campbell PJ; López-Bigas N; ; ; Weischenfeldt J; Beroukhim R; Martincorena I; Pedersen JS; Getz G;
Nature; 2020 Feb; 578(7793):102-111. PubMed ID: 32025015
[TBL] [Abstract][Full Text] [Related]
26. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
27. Core promoter mutation contributes to abnormal gene expression in bladder cancer.
Huang T; Li J; Wang SM
BMC Cancer; 2022 Jan; 22(1):68. PubMed ID: 35033028
[TBL] [Abstract][Full Text] [Related]
28. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide mapping of somatic mutation rates uncovers drivers of cancer.
Sherman MA; Yaari AU; Priebe O; Dietlein F; Loh PR; Berger B
Nat Biotechnol; 2022 Nov; 40(11):1634-1643. PubMed ID: 35726091
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features.
Lanzós A; Carlevaro-Fita J; Mularoni L; Reverter F; Palumbo E; Guigó R; Johnson R
Sci Rep; 2017 Jan; 7():41544. PubMed ID: 28128360
[TBL] [Abstract][Full Text] [Related]
31. A non-coding cancer mutation disrupting an HNF4α binding motif affects an enhancer regulating genes associated to the progression of liver cancer.
Cavalli M; Diamanti K; Pan G; Dabrowski MJ; Komorowski J; Wadelius C
Exp Oncol; 2021 Mar; 43(1):2-6. PubMed ID: 33785712
[TBL] [Abstract][Full Text] [Related]
32. Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.
Zhou S; Treloar AE; Lupien M
Cancer Discov; 2016 Nov; 6(11):1215-1229. PubMed ID: 27807102
[TBL] [Abstract][Full Text] [Related]
33. Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
Lowdon RF; Wang T
PLoS One; 2017; 12(3):e0174032. PubMed ID: 28333948
[TBL] [Abstract][Full Text] [Related]
34. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
Rachakonda PS; Hosen I; de Verdier PJ; Fallah M; Heidenreich B; Ryk C; Wiklund NP; Steineck G; Schadendorf D; Hemminki K; Kumar R
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17426-31. PubMed ID: 24101484
[TBL] [Abstract][Full Text] [Related]
35. Highly recurrent TERT promoter mutations in human melanoma.
Huang FW; Hodis E; Xu MJ; Kryukov GV; Chin L; Garraway LA
Science; 2013 Feb; 339(6122):957-9. PubMed ID: 23348506
[TBL] [Abstract][Full Text] [Related]
36. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.
Nawrocka PM; Galka-Marciniak P; Urbanek-Trzeciak MO; M-Thirusenthilarasan I; Szostak N; Philips A; Susok L; Sand M; Kozlowski P
Front Oncol; 2021; 11():752579. PubMed ID: 34900699
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of recurrent CDC20 promoter variants in human melanoma.
Godoy PM; Oyedeji A; Mudd JL; Morikis VA; Zarov AP; Longmore GD; Fields RC; Kaufman CK
Commun Biol; 2023 Nov; 6(1):1216. PubMed ID: 38030698
[TBL] [Abstract][Full Text] [Related]
38. The Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity.
Petrovski S; Gussow AB; Wang Q; Halvorsen M; Han Y; Weir WH; Allen AS; Goldstein DB
PLoS Genet; 2015 Sep; 11(9):e1005492. PubMed ID: 26332131
[TBL] [Abstract][Full Text] [Related]
39. Occurrence, functionality and abundance of the TERT promoter mutations.
Rachakonda S; Hoheisel JD; Kumar R
Int J Cancer; 2021 Dec; 149(11):1852-1862. PubMed ID: 34313327
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Regulatory DNA Sequences by Dual-Luciferase Reporter Assays in Ewing Sarcoma.
Hölting TLB; Knott MML
Methods Mol Biol; 2021; 2226():139-149. PubMed ID: 33326098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]